CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 91 filers reported holding CUREVAC N V in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $325 | -100.0% | 31,204 | -71.3% | 0.00% | -81.2% |
Q2 2022 | $1,481,000 | +120.7% | 108,876 | +218.0% | 0.02% | +220.0% |
Q1 2022 | $671,000 | -83.3% | 34,236 | -22.2% | 0.01% | -87.8% |
Q1 2021 | $4,024,000 | +792.2% | 44,007 | +689.6% | 0.04% | +355.6% |
Q4 2020 | $451,000 | +56.6% | 5,573 | -10.2% | 0.01% | +12.5% |
Q3 2020 | $288,000 | – | 6,208 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 3,134,780 | $107,600,000 | 32.65% |
Affinity Asset Advisors, LLC | 50,000 | $1,716,000 | 0.62% |
Renaissance Capital LLC | 21,659 | $743,000 | 0.19% |
Eversept Partners, LP | 85,017 | $2,916,933 | 0.19% |
TWINBEECH CAPITAL LP | 67,504 | $2,316,000 | 0.13% |
Alpine Global Management, LLC | 23,033 | $790,000 | 0.12% |
Paradigm Financial Advisors, LLC | 13,535 | $464,000 | 0.10% |
Caption Management, LLC | 200,000 | $6,860,000 | 0.08% |
Baillie Gifford | 3,923,340 | $134,610,000 | 0.07% |
Donoghue Forlines LLC | 11,570 | $397,000 | 0.07% |